BB_LASER_AND_AESTHETICS_C - Accounts


Company registration number 12005160 (England and Wales)
BB LASER AND AESTHETICS CLINIC LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
PAGES FOR FILING WITH REGISTRAR
BB LASER AND AESTHETICS CLINIC LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
BB LASER AND AESTHETICS CLINIC LTD
BALANCE SHEET
AS AT
31 MAY 2023
31 May 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
3,600
7,200
Current assets
Debtors
4
1,692
1,192
Cash at bank and in hand
30,871
32,619
32,563
33,811
Creditors: amounts falling due within one year
5
(9,034)
(7,872)
Net current assets
23,529
25,939
Total assets less current liabilities
27,129
33,139
Provisions for liabilities
(900)
-
0
Net assets
26,229
33,139
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
26,228
33,138
Total equity
26,229
33,139

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 29 February 2024
Mrs N Khan
Director
Company registration number 12005160 (England and Wales)
BB LASER AND AESTHETICS CLINIC LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MAY 2023
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 June 2021
1
31,056
31,057
Year ended 31 May 2022:
Profit and total comprehensive income
-
4,082
4,082
Dividends
-
(2,000)
(2,000)
Balance at 31 May 2022
1
33,138
33,139
Year ended 31 May 2023:
Loss and total comprehensive income
-
(6,910)
(6,910)
Balance at 31 May 2023
1
26,228
26,229
BB LASER AND AESTHETICS CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023
- 3 -
1
Accounting policies
Company information

BB Laser and Aesthetics Clinic Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 396 Forest Road, Walthamstow, London, United Kingdom, E17 5JF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

 

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% Straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

BB LASER AND AESTHETICS CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
1
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

BB LASER AND AESTHETICS CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
1
1
3
Tangible fixed assets
Plant and equipment
£
Cost
At 1 June 2022 and 31 May 2023
18,000
Depreciation and impairment
At 1 June 2022
10,800
Depreciation charged in the year
3,600
At 31 May 2023
14,400
Carrying amount
At 31 May 2023
3,600
At 31 May 2022
7,200
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
1,692
1,192
BB LASER AND AESTHETICS CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2023
- 6 -
5
Creditors: amounts falling due within one year
2023
2022
£
£
Corporation tax
6,672
6,672
Other creditors
2,362
1,200
9,034
7,872
2023-05-312022-06-01false29 February 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityMrs N Khanfalse120051602022-06-012023-05-31120051602023-05-31120051602022-05-3112005160core:PlantMachinery2023-05-3112005160core:PlantMachinery2022-05-3112005160core:CurrentFinancialInstrumentscore:WithinOneYear2023-05-3112005160core:CurrentFinancialInstrumentscore:WithinOneYear2022-05-3112005160core:CurrentFinancialInstruments2023-05-3112005160core:CurrentFinancialInstruments2022-05-3112005160core:ShareCapital2023-05-3112005160core:ShareCapital2022-05-3112005160core:RetainedEarningsAccumulatedLosses2023-05-3112005160core:RetainedEarningsAccumulatedLosses2022-05-3112005160core:ShareCapital2021-05-3112005160core:RetainedEarningsAccumulatedLosses2021-05-3112005160bus:Director12022-06-012023-05-3112005160core:RetainedEarningsAccumulatedLosses2021-06-012022-05-31120051602021-06-012022-05-3112005160core:RetainedEarningsAccumulatedLosses2022-06-012023-05-3112005160core:PlantMachinery2022-06-012023-05-3112005160core:PlantMachinery2022-05-3112005160core:WithinOneYear2023-05-3112005160core:WithinOneYear2022-05-3112005160bus:PrivateLimitedCompanyLtd2022-06-012023-05-3112005160bus:SmallCompaniesRegimeForAccounts2022-06-012023-05-3112005160bus:FRS1022022-06-012023-05-3112005160bus:AuditExempt-NoAccountantsReport2022-06-012023-05-3112005160bus:FullAccounts2022-06-012023-05-31xbrli:purexbrli:sharesiso4217:GBP